Honggang Zhou

20PUBLICATIONS
26CO-AUTHORS
Molecular targetsMolecular medicineEpigenetics (incl. genome methylation and epigenomics)Tissue engineeringGlycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jul 28, 2026
A Derivative of Plumbagin Targets the JAK2/STAT3 Pathway to Inhibit the Progression of Oral Squamous Cell Carcinoma.

|May 27, 2026
Correction: Li et al. Zanubrutinib Ameliorates Cardiac Fibrosis and Inflammation Induced by Chronic Sympathetic Activation. Molecules 2023, 28, 6035.

|Nov 27, 2025
The Genetic and Embryo-Fetal Developmental Toxicity Profile of the Novel Transgelin Agonist Deg-AZM: Ames, Micronucleus, Chromosomal Aberration, and Rat EFD Studies.

Xiaoting Gu, Ying Xu, Nannan Liu

|Sep 27, 2025
Oleuropein Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Mice by Targeting TGF-β1 Signaling Pathway.

Liang Zhang, Zhigang Liu, Yayue Hu

|Sep 27, 2025
Preclinical Safety Profile of Deg-AZM, a Clinical-Stage New Transgelin Agonist: hERG Inhibition Study In Vitro, Cardiovascular-Respiratory Pharmacology, and Single/Repeated-Dose Toxicity in Beagle Dogs.

Xiaoting Gu, Xiaohe Li, Hailong Li

|May 09, 2025
PAR1 inhibition sensitizes HPV-negative HNSCC cells to ferroptosis through inhibition of the STAT3-mediated regulation of iron and lipid metabolic pathways.

Jiao Tian, Chaoge Liu, Bing Li

Pageof 4

Frequent Collaborators

2 joint publications

Hao Ruan

2 joint publications

Wenqi Li

2 joint publications

Cheng Yang

1 joint publications

Shuaibo Shao